Willumsen, Nicholas http://orcid.org/0000-0002-5207-5173
Jensen, Christina
Green, George
Nissen, Neel I.
Neely, Jaclyn
Nelson, David M.
Pedersen, Rasmus S.
Frederiksen, Peder
Chen, Inna M.
Boisen, Mogens K.
Johansen, Astrid Z.
Madsen, Daniel H.
Svane, Inge Marie
Lipton, Allan
Leitzel, Kim
Ali, Suhail M.
Erler, Janine T.
Hurkmans, Daan P.
Mathijssen, Ron H. J.
Aerts, Joachim
Eslam, Mohammed
George, Jacob
Christiansen, Claus
Bissel, Mina J.
Karsdal, Morten A.
Article History
Received: 7 December 2021
Revised: 15 February 2022
Accepted: 28 February 2022
First Online: 25 March 2022
Declarations
:
: NW is employed and have stockownership and patents in Nordic Bioscience. CJ is employed at Nordic Bioscience. GG is employed and have stockownership and patents or other related intellectual property in Bristol Myers Squibb. NIN is employed in Nordic Bioscience. JN is employed and have stockownership in Bristol Myers Squibb. DMN is employed and have stockownership and patents or other related intellectual property in Bristol Myers Squibb. PF is employed in Nordic Bioscience. RSP is employed in Nordic Bioscience. IMC declares a consultancy/advisory role at Amgen, to have received research funding from Bristol Myers Squibb, Roche, Genis TILT, Lytix and travels expenses paid by Bristol Myers Squibb, Roche, Bayer. MKB declares no competing interests. AZJ declares no competing interests. DHM declares no competing interests. IMS declares paid honoraria from IO Biotech, MSD, a consultancy/advisory role at Pierre Fabre and Novartis, to have received research funding from Bristol Myers Squibb, Roche, TILT, Lytix and travels expenses paid by MSD. AL declares no competing interests. KL declares no competing interests. SMA declares no competing interests. JTE is a founder and CEO of LOXiGen ApS and was CEO of LOXiPharm IVS. DPH declares no competing interests. RHJM declares a consultancy/advisory role at Servier, to have received research funding from Astellas, Bayer, BI, Cristal tx, Pamgene, Pfizer, Novastis, Roche, Servier, Sanofi and to have patents or other related intellectual property pending at Pamgene. JA declares to have patents or other related intellectual property at Amphera and travels expenses paid by MSD. ME declares paid honoraria from Sanofi and a consultancy/advisory role at Pfizer. JG declares paid honoraria and a consultancy/advisory role at Roche, MSD, Pfizer, Abbvie, AstraZeneca, Novartis, Pharmaxis, Cincera, Novo, Gilead, Norgine, Eisai. CC have stockownership and patents in Nordic Bioscience. MBL declares no competing interests. MK is employed and have stockownership and patents in Nordic Bioscience.
: Not applicable.
: Not applicable.